Important on @moderna_tx vaccine trial for reducing transmission from FDA briefing docs https://t.co/GAUikTXvYdThey did nasal swabs after 1st dose and showed reduction of asymptomatic infections, reflecting impact on blocking transmission. Very encouraging! pic.twitter.com/6IVSj8E3F0— Eric Topol (@EricTopol) December 15, 2020
Important on @moderna_tx vaccine trial for reducing transmission from FDA briefing docs https://t.co/GAUikTXvYdThey did nasal swabs after 1st dose and showed reduction of asymptomatic infections, reflecting impact on blocking transmission. Very encouraging! pic.twitter.com/6IVSj8E3F0